Abstract:Siyun Li, 1 Fuzhen Feng, 2 Yanhui Deng 1 1 Department of Pharmacy, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People's Republic of China; 2 Department of Pharmacy, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, People's Republic of China Correspondence: Yanhui Deng, Department of Pharmacy, The Third Affiliated Hospital of Southern Medical University, 183 West Zhongshan Road, Tianhe District, Guangzhou, 510630, People's Republic of China, Tel +86 020 62784810, Email Purpose: To explore the underlying mechanism of the anti-diabetic effect of resveratrol (RSV) on regulating glycolipid metabolism in diabetic rats induced by streptozotocin (STZ) and a high-fat diet (HFD). Methods: Male Wistar rats were randomized into three groups. Two groups were fed a high-fat diet and intraperitoneally injected with STZ (35 mg/kg), with one group also treated with RSV (30 mg/kg/d), and the third, control group was fed a normal diet. After 12 weeks, blood lipid levels and fasting blood glucose (FBG) were assessed. Histopathological changes were evaluated by hematoxylin-eosin (HE) staining and periodic acid-Schiff (PAS) staining. The protein expression of hypoxia-inducible factor 1α (HIF-1α) was assessed by Western blotting and immunofluorescence, and the proteins level of 3-phosphoinositide-dependent protein kinase 1 (PDK1), phosphorylated-PDK1 (p-PDK1), phosphorylated-protein kinase B (p-AKT), glucose transporter 1 (GLUT1) and low-density lipoprotein receptor (LDLR) in the liver were analyzed by Western blotting. The mRNA levels of Hif-1α, Glut1 and Ldlr in the liver were determined by RT-qPCR. Results: RSV treatment significantly reduced liver/body weight ratio (L/W, P < 0.05), FBG ( P < 0.01) and serum concentrations of total cholesterol (TC, P < 0.05), triglycerides (TG, P < 0.01) and low-density lipoprotein-cholesterol (LDL-C, P < 0.05) in diabetic rats. RSV also improved diabetic symptoms, attenuated liver steatosis and increased liver glycogen accumulation. RSV treatment significantly downregulated the proteins expression of p-PDK1 and p-AKT ( P < 0.01) and the levels of HIF-1α ( P < 0.05) and GLUT1 ( P < 0.01), while significantly upregulating the level of LDLR ( P < 0.05). Conclusion: RSV was effective in improving glycolipid metabolism in diabetic rats, probably by inhibiting the PDK1/AKT/HIF-1α pathway and regulation of its downstream target levels. These findings may provide new insight into the mechanism of action of RSV in the treatment of diabetes. Keywords: resveratrol, diabetes, glycolipid metabolism, PDK1, AKT, HIF-1α Type 2 diabetes mellitus (T2DM), a chronic endocrine and metabolic disease influenced by genetic and environmental factors, has become a severe issue worldwide because of its rapidly increasing rates and accompanying economic and social burdens. 1 The pathogenesis of this disease is complicated, including autophagy, oxidative stress, metabolic disorders with sustained insulin resistance, inflammation, hypoxia and other factors. Metabolic disorders are regarded as risk factors for the occurrence and development of T2DM, as metabolic disorders can exacerbate inflammatory reactions, obstruct the interaction of insulin receptors with glucose transporters, and compromise β-cell function. Additionally, insulin resistance, a characteristic of irregular glucose metabolism, can increase the concentrations of free fatty acids (FFA) and TG in serum lipids, resulting in dyslipidemia. 2 Although these findings suggest interactions between glucose metabolism and lipid metabolism, the underlying mechanisms remain unclear. 3 The AKT pathway has been found to regulate glycolipid metabolism, suggesting that this pathway may be a target in the treatment of diabetes. 4 This pathway is initiated by the phosphorylation of AKT by PDK1 which acts upstream of AKT, thereby enhancing glucose uptake and utilization. 5 Hypoxia-inducible factors (HIFs), which are composed of an oxygen-sensitive α-subunit and a constitutively expressed β-subunit, are critical to regulating adaptive responses to hypoxia. Additionally, the α-subunit, which is rapidly metabolized by the proteasome under normoxic conditions, is stabilized under hypoxic conditions. 6 HIF-1α is a downstream target of the AKT pathway that is involved in cancer, including in cancer-associated inflammation, mitochondrial metabolism and angiogenesis. 7 Moreover, activation of AKT signaling was found to increase the rate of HIF-1α synthesis. 8 In addition to -Abstract Truncated-

Resveratrol Suppresses the STAT 3 Signaling Pathway and Inhibits Proliferation of High Glucose-Exposed HepG 2 Cells Partly Through SIRT 1

STAT1 Inhibits Human Hepatocellular Carcinoma Cell Growth Through Induction of P53 and Fbxw7

Resveratrol Inhibits Hyperglycemia-Driven ROS-induced Invasion and Migration of Pancreatic Cancer Cells Via Suppression of the ERK and P38 MAPK Signaling Pathways.

Resveratrol Inhibits Invasion and Metastasis of Hepatocellular Carcinoma Cells

Inhibitory Effect of Resveratrol on High Glucose-Induced Proliferation of Mesangial Cells

Inhibition of Liver Cancer Cell Growth by Triethylsilyl Resveratrol through Targeting Phosphoinositide-3 Kinase Pathway

The protective role of resveratrol against high glucose-induced oxidative stress and apoptosis in HepG2 cells

Resveratrol Suppresses Colon Cancer Growth by Targeting the AKT/STAT3 Signaling Pathway.

Regulation of Proliferation and Autophagy and Its Possible Mechanisms of Resveratrol on HepG2 Cells in Hypoxia

GRIM‑19‑mediated Stat3 activation is a determinant for resveratrol‑induced proliferation and cytotoxicity in cervical tumor‑derived cell lines.

Resveratrol attenuates high glucose-induced inflammation and improves glucose metabolism in HepG2 cells

Resveratrol Inhibits Hexokinases II Mediated Glycolysis in Non-Small Cell Lung Cancer Via Targeting Akt Signaling Pathway

Effects of Resveratrol on Cell Proliferation in Glomerular Mesangial Cells Cultured under High Glucose by Inhibiting SphK1/AP-1 Signal Pathway

Resveratrol modulates signalling to inhibit vascular smooth muscle cell proliferation induced by angiotensin II and high glucose

Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK

SIRT3 suppression resulting from the enhanced β-catenin signaling drives glycolysis and promotes hypoxia-induced cell growth in hepatocellular carcinoma cells

Resveratrol Regulates Glucose and Lipid Metabolism in Diabetic Rats by Inhibition of PDK1/AKT Phosphorylation and HIF-1α Expression

Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line

Resveratrol Inhibits Insulin-Induced Vascular Smooth Muscle Cell Proliferation and Migration by Activating SIRT1

Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner

Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation.